A litter of rat pups, exposed to a common “forever chemical” before birth, grew up to act more impulsively and show measurable gene activity changes in two brain regions that govern self-control. The chemical was perfluorooctane sulfonate, better known as PFOS, one of the most widespread and persistent compounds in the family of per- and polyfluoroalkyl substances (PFAS) that contaminate drinking water, food packaging, and firefighting foam across the United States.
The study, published in Neurotoxicology and Teratology in 2025 by researchers including Sarah E. Chang and colleagues and indexed on PubMed Central, exposed pregnant rats to PFOS during gestation and early nursing, then examined gene expression in the offspring’s nucleus accumbens and prefrontal cortex. The first region drives reward-seeking and motivation; the second handles planning and the ability to stop before acting. Both showed significant shifts in gene activity compared to unexposed controls. A mediation analysis, a statistical method that tests whether one variable sits on the causal path between two others, linked those molecular changes to the impulsive, cognitively impaired behavior the animals displayed during standardized testing. In other words, the gene shifts were not just present alongside the behavioral problems; they statistically accounted for part of the connection between PFOS exposure and impaired performance.
A pattern across species and brain regions
This is not the first animal experiment to flag PFOS as a neurodevelopmental disruptor, but it is among the most detailed in tracing a path from chemical exposure through molecular change to behavioral outcome. Earlier work using a cross-foster design, which separates prenatal from postnatal exposure windows, found that PFOS altered gene expression profiles in developing rat cerebral cortex. A separate study documented long-lasting changes in synaptic proteins, specifically synapsins and synaptophysin, in the hippocampus of exposed offspring, a region critical for memory and spatial learning. Mouse research published in Toxicological Sciences added evidence that early postnatal PFOS exposure disrupted proteins involved in neuronal growth and synapse formation, including CaMKII and GAP-43.
The pattern extends beyond rodents. In zebrafish larvae, developmental PFOS exposure produced spontaneous hyperactivity that was reversed by dexamfetamine, a stimulant prescribed for ADHD that acts on dopamine signaling. That a dopamine-targeting drug corrected the behavior suggests PFOS may be disrupting the same neurotransmitter pathways that malfunction in human attention and impulse-control disorders, though zebrafish brains differ substantially from mammalian ones, and the parallel has limits.
Taken together, these experiments span rats, mice, and fish, cover the prefrontal cortex, nucleus accumbens, hippocampus, and cerebral cortex, and target exposure windows from early gestation through the postnatal period. The convergence across species and brain structures strengthens the case that PFOS can durably alter the molecular machinery behind learning and behavioral regulation.
Where regulation stands
The U.S. Environmental Protection Agency finalized an enforceable drinking water standard for PFOS in April 2024, setting the maximum contaminant level at 4 parts per trillion. The limit was driven primarily by evidence of immune system harm and other non-cancer health effects, but the agency’s broader human health toxicity assessment for PFOS includes animal neurodevelopment data in its weight-of-evidence framework. That means laboratory findings like the ones described here feed into the scientific foundation regulators use when deciding how much PFOS is too much in tap water, even if neurotoxicity alone did not set the current threshold.
Public water systems across the country are now working to comply with the new limit, but PFOS exposure is not confined to drinking water. The chemical persists in soil near military bases and airports where firefighting foam was used for decades, accumulates in certain fish and shellfish, and lingers in older consumer products. Blood monitoring by the Centers for Disease Control and Prevention has found detectable PFOS levels in the vast majority of Americans tested, though concentrations have declined since the compound was phased out of U.S. manufacturing in the early 2000s.
What the science has not settled
The most important limitation is the gap between animal brains and human ones. No study has measured PFOS-driven gene expression changes in living human brain tissue, and ethical constraints make that experiment essentially impossible. Epidemiological research has linked PFAS exposure to attention problems and behavioral difficulties in children, but population-level associations cannot identify the specific molecular pathways a rat study can isolate. Whether the gene networks disrupted in rat prefrontal cortex and nucleus accumbens operate the same way in a child’s developing brain remains unproven.
Dose is another sticking point. Animal studies typically use PFOS concentrations higher than what most people encounter, though blood levels in heavily contaminated communities can approach the lower end of experimental ranges. Metabolic differences between species further complicate direct comparisons. The mediation analysis in the central study is a powerful statistical tool, but it identifies plausible pathways rather than proving causation in the way a controlled intervention would. Replication in independent labs, and ideally in non-rodent mammals, would strengthen confidence considerably.
Most of the supporting studies also measured outcomes at relatively young ages. Whether PFOS-driven gene shifts persist into adulthood, intensify, or partially resolve as the brain compensates through normal plasticity is an open question. And while the zebrafish finding that dexamfetamine reversed hyperactivity is provocative, no one has tested whether the same pharmacological rescue works in PFOS-exposed rats or primates.
What this means for the bigger PFAS picture
PFOS is just one compound in a family of thousands of PFAS chemicals, many of which remain poorly studied. The neurodevelopmental evidence is strongest for PFOS because it was manufactured in enormous volumes for decades and has been the focus of the most research. Whether structurally similar compounds, such as the shorter-chain replacements now used in manufacturing, carry the same risks to developing brains is largely unknown. As of May 2026, regulatory and scientific attention continues to expand beyond PFOS and PFOA to the broader class, but the toxicology has not kept pace with the chemistry.
For parents and expectant mothers concerned about exposure, the most actionable steps remain practical: checking whether local water systems have been tested for PFAS, using certified point-of-use filters where contamination is documented, and following state fish consumption advisories in areas with known PFAS pollution. The animal research described here does not establish that typical human exposures cause the same brain changes seen in rats, but it sharpens the biological rationale for minimizing contact with these chemicals during pregnancy and early childhood, the windows when the brain is most vulnerable to chemical interference.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
